This head-to-head study tracked real-world data from 58,336 Medicare patients treated with either semaglutide or dulaglutide
But: Considering these are prescription drugs, not over-the-counter wellness buys, choosing the right provider mattersand not every service offering GLP-1s actually supports safe, supervised microdosing
For additional details see Appendix S2
Serious risks include pancreatitis (stop medication and seek immediate medical attention for severe abdominal pain radiating to the back), gallbladder disease, acute kidney injury (typically secondary to dehydration from gastrointestinal symptoms), and hypersensitivity reactions
Int J Mol Sci 22:3487 Pilleri M, Antonini A (2015) Therapeutic strategies to prevent and manage dyskinesias in Parkinsons disease
Guerreiro SFC, Dias AG, Dias JR, Granja PL